← All trials
NCT05828745
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2023
- Primary completion
- Mar 27, 2024
- Completion date
- Mar 30, 2024
- First posted
- Apr 25, 2023
- Last posted
- Apr 25, 2023
- Enrollment
- 40
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Zhimeng Biopharma, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.